Literature DB >> 27243019

Does the Intestinal Microbiota Explain Differences in the Epidemiology of Liver Disease between East and West?

Nobuhiro Nakamoto1, Bernd Schnabl2.   

Abstract

Changes in bacterial communities are associated with the pathogenesis of many diseases including inflammatory bowel disease and liver disease. Dysbiosis can induce intestinal inflammation resulting in increased intestinal permeability and bacterial translocation. The majority of chronic liver diseases are associated with bacterial translocation resulting in or enhancing an inflammatory response in the liver. Intestinal inflammation and a dysfunctional intestinal barrier are not sufficient to cause liver disease in the absence of an additional liver insult. In this article, the authors summarize differences in intestinal microbiota composition between Eastern and Western countries. The authors specifically discuss whether differences in microbiota composition could explain the epidemiological differences in liver disease found in Asia and Europe/the USA.

Entities:  

Keywords:  East and West; Inflammatory bowel disease; Liver disease; Microbiota; Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis

Year:  2016        PMID: 27243019      PMCID: PMC4883108          DOI: 10.1159/000443196

Source DB:  PubMed          Journal:  Inflamm Intest Dis        ISSN: 2296-9365


  45 in total

1.  Colonic microbiome is altered in alcoholism.

Authors:  Ece A Mutlu; Patrick M Gillevet; Huzefa Rangwala; Masoumeh Sikaroodi; Ammar Naqvi; Phillip A Engen; Mary Kwasny; Cynthia K Lau; Ali Keshavarzian
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-01-12       Impact factor: 4.052

2.  Commensal microbiota is hepatoprotective and prevents liver fibrosis in mice.

Authors:  Magdalena Mazagova; Lirui Wang; Andrew T Anfora; Max Wissmueller; Scott A Lesley; Yukiko Miyamoto; Lars Eckmann; Suraj Dhungana; Wimal Pathmasiri; Susan Sumner; Caroline Westwater; David A Brenner; Bernd Schnabl
Journal:  FASEB J       Date:  2014-12-02       Impact factor: 5.191

3.  Nationwide survey for primary sclerosing cholangitis and IgG4-related sclerosing cholangitis in Japan.

Authors:  Atsushi Tanaka; Susumu Tazuma; Kazuichi Okazaki; Hirohito Tsubouchi; Kazuo Inui; Hajime Takikawa
Journal:  J Hepatobiliary Pancreat Sci       Date:  2013-10-29       Impact factor: 7.027

4.  Enterotypes of the human gut microbiome.

Authors:  Manimozhiyan Arumugam; Jeroen Raes; Eric Pelletier; Denis Le Paslier; Takuji Yamada; Daniel R Mende; Gabriel R Fernandes; Julien Tap; Thomas Bruls; Jean-Michel Batto; Marcelo Bertalan; Natalia Borruel; Francesc Casellas; Leyden Fernandez; Laurent Gautier; Torben Hansen; Masahira Hattori; Tetsuya Hayashi; Michiel Kleerebezem; Ken Kurokawa; Marion Leclerc; Florence Levenez; Chaysavanh Manichanh; H Bjørn Nielsen; Trine Nielsen; Nicolas Pons; Julie Poulain; Junjie Qin; Thomas Sicheritz-Ponten; Sebastian Tims; David Torrents; Edgardo Ugarte; Erwin G Zoetendal; Jun Wang; Francisco Guarner; Oluf Pedersen; Willem M de Vos; Søren Brunak; Joel Doré; María Antolín; François Artiguenave; Hervé M Blottiere; Mathieu Almeida; Christian Brechot; Carlos Cara; Christian Chervaux; Antonella Cultrone; Christine Delorme; Gérard Denariaz; Rozenn Dervyn; Konrad U Foerstner; Carsten Friss; Maarten van de Guchte; Eric Guedon; Florence Haimet; Wolfgang Huber; Johan van Hylckama-Vlieg; Alexandre Jamet; Catherine Juste; Ghalia Kaci; Jan Knol; Omar Lakhdari; Severine Layec; Karine Le Roux; Emmanuelle Maguin; Alexandre Mérieux; Raquel Melo Minardi; Christine M'rini; Jean Muller; Raish Oozeer; Julian Parkhill; Pierre Renault; Maria Rescigno; Nicolas Sanchez; Shinichi Sunagawa; Antonio Torrejon; Keith Turner; Gaetana Vandemeulebrouck; Encarna Varela; Yohanan Winogradsky; Georg Zeller; Jean Weissenbach; S Dusko Ehrlich; Peer Bork
Journal:  Nature       Date:  2011-04-20       Impact factor: 49.962

5.  A microbial symbiosis factor prevents intestinal inflammatory disease.

Authors:  Sarkis K Mazmanian; June L Round; Dennis L Kasper
Journal:  Nature       Date:  2008-05-29       Impact factor: 49.962

6.  Dynamics and associations of microbial community types across the human body.

Authors:  Tao Ding; Patrick D Schloss
Journal:  Nature       Date:  2014-04-16       Impact factor: 49.962

7.  Linking long-term dietary patterns with gut microbial enterotypes.

Authors:  Gary D Wu; Jun Chen; Christian Hoffmann; Kyle Bittinger; Ying-Yu Chen; Sue A Keilbaugh; Meenakshi Bewtra; Dan Knights; William A Walters; Rob Knight; Rohini Sinha; Erin Gilroy; Kernika Gupta; Robert Baldassano; Lisa Nessel; Hongzhe Li; Frederic D Bushman; James D Lewis
Journal:  Science       Date:  2011-09-01       Impact factor: 47.728

8.  Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity.

Authors:  Jorge Henao-Mejia; Eran Elinav; Chengcheng Jin; Liming Hao; Wajahat Z Mehal; Till Strowig; Christoph A Thaiss; Andrew L Kau; Stephanie C Eisenbarth; Michael J Jurczak; Joao-Paulo Camporez; Gerald I Shulman; Jeffrey I Gordon; Hal M Hoffman; Richard A Flavell
Journal:  Nature       Date:  2012-02-01       Impact factor: 49.962

9.  Innate immunity and intestinal microbiota in the development of Type 1 diabetes.

Authors:  Li Wen; Ruth E Ley; Pavel Yu Volchkov; Peter B Stranges; Lia Avanesyan; Austin C Stonebraker; Changyun Hu; F Susan Wong; Gregory L Szot; Jeffrey A Bluestone; Jeffrey I Gordon; Alexander V Chervonsky
Journal:  Nature       Date:  2008-09-21       Impact factor: 49.962

10.  Diversity in gut bacterial community of school-age children in Asia.

Authors:  Jiro Nakayama; Koichi Watanabe; Jiahui Jiang; Kazunori Matsuda; Shiou-Huei Chao; Pri Haryono; Orawan La-Ongkham; Martinus-Agus Sarwoko; I Nengah Sujaya; Liang Zhao; Kang-Ting Chen; Yen-Po Chen; Hsueh-Hui Chiu; Tomoko Hidaka; Ning-Xin Huang; Chikako Kiyohara; Takashi Kurakawa; Naoshige Sakamoto; Kenji Sonomoto; Kousuke Tashiro; Hirokazu Tsuji; Ming-Ju Chen; Vichai Leelavatcharamas; Chii-Cherng Liao; Sunee Nitisinprasert; Endang S Rahayu; Fa-Zheng Ren; Ying-Chieh Tsai; Yuan-Kun Lee
Journal:  Sci Rep       Date:  2015-02-23       Impact factor: 4.379

View more
  3 in total

1.  Inflammatory Intestinal Diseases: Why Do We Need Another Gastroenterology Journal?

Authors:  Gerhard Rogler; Toshifumi Hibi
Journal:  Inflamm Intest Dis       Date:  2016-04-02

2.  Rifaximin ameliorates hepatic encephalopathy and endotoxemia without affecting the gut microbiome diversity.

Authors:  Kosuke Kaji; Hiroaki Takaya; Soichiro Saikawa; Masanori Furukawa; Shinya Sato; Hideto Kawaratani; Mitsuteru Kitade; Kei Moriya; Tadashi Namisaki; Takemi Akahane; Akira Mitoro; Hitoshi Yoshiji
Journal:  World J Gastroenterol       Date:  2017-12-21       Impact factor: 5.742

Review 3.  Microbiota dysbiosis and barrier dysfunction in inflammatory bowel disease and colorectal cancers: exploring a common ground hypothesis.

Authors:  Linda Chia-Hui Yu
Journal:  J Biomed Sci       Date:  2018-11-09       Impact factor: 8.410

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.